With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

PCI Express* architecture as a new chip-to-chip interconnect and Advanced Switching based on PCI Express architecture for system fabrics are positioned to offer overwhelming benefits to the ...